Latest Stories

Menarini brings Nobel Prize-winning scientist to Manila

Nobel prize-winning scientist recently shared his expertise with local cardiologists.

Prof. Louis J. Ignarro spoke during the 44th annual convention of the Philippine Heart Association (PHA), which was held at the Edsa Shangri-La Hotel in Mandaluyong City. His talk was viewed simultaneously via live streaming by PHA members in Baguio, Pampanga, Batangas and Davao.

This is in line with A. Menarini Philippines’ commitment to enhance the quality of cardiovascular disease management in the country.

A distinguished professor of Pharmacology at the UCLA School of Medicine in California, Ignarro received the Nobel Prize in Medicine in 1998 for his discovery that nitric oxide is produced in the blood vessels and controls the flow of blood by signaling the vessels to expand and contract.

“By causing blood vessels to widen, nitric oxide improves blood flow and lowers blood pressure,” Ignarro said.

With the theme “PHA@60: Strategies, Realities and Networks,” this year’s annual convention coincided with PHA’s 60th anniversary and was aimed at equipping Filipino cardiologists and physicians with the latest updates and innovations in cardiovascular medicine.

PHA president Dr. Saturnino Javier said: “We are honored to have Prof. Ignarro as a speaker in our annual convention. His extensive research on cardiovascular health and discovery of the role of nitric oxide have contributed significantly to the effective treatment of cardiovascular diseases.”

“Prof. Ignarro’s groundbreaking discovery of nitric oxide’s role in cardiovascular health paved the way for the development of effective treatments against hypertension,” said Dr. Dante Morales, Manila Doctors Hospital senior vice president for medical affairs. “Hypertension is a major risk factor for cardiovascular disease, the leading cause of death in the country.”

Congratulating the PHA on its 60th anniversary, A. Menarini Philippines general manager Ninia Torres said, “We fully support the association’s noble mission to ensure accessible, affordable and quality cardiovascular care for every Filipino.” A. Menarini Philippines is the local affiliate of Italy’s leading research-based pharmaceutical  company, the Menarini Group.

“Menarini is committed to working with Filipino physicians in reducing the burden of hypertension in the Philippines,” said John Graham,  A. Menarini Asia Pacific Pte. Ltd. chief executive officer.

Menarini recently introduced nebivolol in the Philippines. Nebivolol is the only beta blocker known to induce vascular production of nitric oxide. Available in Europe since 1999, nebivolol is indicated for the treatment of essential hypertension, and mild and moderate chronic heart failure in addition to standard therapies in elderly patients.

Follow Us

Follow us on Facebook Follow on Twitter Follow on Twitter

Recent Stories:

Complete stories on our Digital Edition newsstand for tablets, netbooks and mobile phones; 14-issue free trial. About to step out? Get breaking alerts on your mobile.phone. Text ON INQ BREAKING to 4467, for Globe, Smart and Sun subscribers in the Philippines.

Tags: cardiology , Health , nobel prize winner , Philippine heart association

Copyright © 2014, .
To subscribe to the Philippine Daily Inquirer newspaper in the Philippines, call +63 2 896-6000 for Metro Manila and Metro Cebu or email your subscription request here.
Factual errors? Contact the Philippine Daily Inquirer's day desk. Believe this article violates journalistic ethics? Contact the Inquirer's Reader's Advocate. Or write The Readers' Advocate:
c/o Philippine Daily Inquirer Chino Roces Avenue corner Yague and Mascardo Streets, Makati City, Metro Manila, Philippines Or fax nos. +63 2 8974793 to 94


  • After quake, makeshift churches welcome pilgrims in Bohol
  • UN warns banana fungus spreading from Southeast Asia
  • Massive infra spending set
  • ‘No real progress in PH if dynasties not dismantled’
  • Cardinal Tagle to faithful: Join politics to clean it
  • Sports

  • Federer would skip tennis to be with wife, newborn
  • Manny Pacquiao in PBA? If so, he’ll wear No. 17
  • PSC sets Blu Girls US training
  • Power Pinoys settle for 7th place
  • Successful coaches to get raise
  • Lifestyle

  • ‘Labahita a la bacalao’
  • This is not just a farm
  • Clams and garlic, softshell crab risotto–not your usual seafood fare for Holy Week
  • Moist, extra-tender blueberry muffins
  • The truffled mac ‘n’ cheese, eggs benedict, chicken leg confit are excellent
  • Entertainment

  • Why Lucky has not bought an engagement ring for Angel
  • Derek more private with new girlfriend
  • ‘Community’ star happy with return of show’s creator
  • Jealousy is kid stuff
  • Mommy-daughter adventure continues
  • Business

  • PH presses bid to keep rice import controls
  • PSEi continues to gain
  • Number of retrenched workers rose by 42% in ’13
  • PH seen to sustain rise in FDIs
  • Gov’t subsidies to state firms fell in first 2 months
  • Technology

  • Smart phone apps and sites perfect for the Holy Week
  • Tech company: Change passwords or suffer ‘Heartbleed’
  • Filling the digital talent gap
  • SSS to shut down website for Holy Week
  • Another reason to quit social media this Holy Week: your safety
  • Opinion

  • Editorial cartoon, April 17, 2014
  • A humbler Church
  • Deepest darkness
  • ‘Agnihotra’ for Earth’s health
  • It’s the Holy Week, time to think of others
  • Global Nation

  • First Fil-Am elected to Sierra Madre, Calif. city council
  • UC Irvine cultural night to dramatize clash of values in immigrant family
  • Filipino sweets and info served at UC Berkeley Spring Fest
  • Milpitas, California kids wrap up a successful run of ‘The Wiz’
  • Netizens welcome Japan’s visa-free travel plan
  • Marketplace